应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CABA Cabaletta Bio
未开盘 07-14 16:00:00 EDT
1.69
-0.05
-2.87%
盘后
1.74
+0.05
+2.96%
18:57 EDT
最高
1.77
最低
1.65
成交量
126.44万
今开
1.76
昨收
1.74
日振幅
6.90%
总市值
1.52亿
流通市值
1.40亿
总股本
8,994万
成交额
213.94万
换手率
1.53%
流通股本
8,263万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Cabaletta Bio, Inc.盘中异动 急速下挫5.14%
市场透视 · 07-14 16:04
Cabaletta Bio, Inc.盘中异动 急速下挫5.14%
Cabaletta Bio, Inc.盘中异动 股价大涨5.26%报1.59美元
市场透视 · 07-09
Cabaletta Bio, Inc.盘中异动 股价大涨5.26%报1.59美元
Cabaletta Bio, Inc.盘中异动 早盘快速下挫5.83%报1.54美元
市场透视 · 07-07
Cabaletta Bio, Inc.盘中异动 早盘快速下挫5.83%报1.54美元
Cabaletta Bio, Inc.盘中异动 快速上涨5.22%
市场透视 · 07-01
Cabaletta Bio, Inc.盘中异动 快速上涨5.22%
Cabaletta Bio, Inc.盘中异动 临近收盘股价大跌5.29%
市场透视 · 06-27
Cabaletta Bio, Inc.盘中异动 临近收盘股价大跌5.29%
Cabaletta Bio, Inc.盘中异动 股价大跌5.08%报1.68美元
市场透视 · 06-26
Cabaletta Bio, Inc.盘中异动 股价大跌5.08%报1.68美元
Cabaletta Bio, Inc.盘中异动 下午盘股价大涨5.16%报1.82美元
市场透视 · 06-20
Cabaletta Bio, Inc.盘中异动 下午盘股价大涨5.16%报1.82美元
Cabaletta Bio, Inc.盘中异动 股价大跌5.09%
市场透视 · 06-18
Cabaletta Bio, Inc.盘中异动 股价大跌5.09%
Cabaletta Bio, Inc.盘中异动 早盘急速跳水5.03%报1.89美元
市场透视 · 06-16
Cabaletta Bio, Inc.盘中异动 早盘急速跳水5.03%报1.89美元
Cabaletta Bio, Inc.盘中异动 早盘股价大涨5.08%报1.84美元
市场透视 · 06-12
Cabaletta Bio, Inc.盘中异动 早盘股价大涨5.08%报1.84美元
Cabaletta Bio, Inc.盘中异动 早盘股价大跌19.57%
市场透视 · 06-11
Cabaletta Bio, Inc.盘中异动 早盘股价大跌19.57%
Cabaletta Bio, Inc.盘中异动 急速跳水5.04%
市场透视 · 06-09
Cabaletta Bio, Inc.盘中异动 急速跳水5.04%
Cabaletta Bio, Inc.盘中异动 早盘快速拉升5.05%
市场透视 · 06-06
Cabaletta Bio, Inc.盘中异动 早盘快速拉升5.05%
Cabaletta Bio, Inc.盘中异动 早盘股价大跌5.10%
市场透视 · 06-05
Cabaletta Bio, Inc.盘中异动 早盘股价大跌5.10%
Cabaletta Bio, Inc.盘中异动 早盘快速上涨5.35%
市场透视 · 06-02
Cabaletta Bio, Inc.盘中异动 早盘快速上涨5.35%
Cabaletta Bio, Inc.盘中异动 股价大跌5.31%
市场透视 · 05-21
Cabaletta Bio, Inc.盘中异动 股价大跌5.31%
Cabaletta Bio, Inc.盘中异动 大幅下跌5.21%报1.82美元
市场透视 · 05-20
Cabaletta Bio, Inc.盘中异动 大幅下跌5.21%报1.82美元
Cabaletta Bio(CABA.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.71美元,前值为-0.51美元,预期值为-0.66美元。
金融界 · 05-19
Cabaletta Bio(CABA.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.71美元,前值为-0.51美元,预期值为-0.66美元。
Cabaletta Bio, Inc.盘中异动 大幅跳水5.22%
市场透视 · 05-19
Cabaletta Bio, Inc.盘中异动 大幅跳水5.22%
花旗:维持Cabaletta Bio(CABA.US)评级,由买入调整至买入评级, 目标价由17.00美元调整至13.00美元。
金融界 · 05-16
花旗:维持Cabaletta Bio(CABA.US)评级,由买入调整至买入评级, 目标价由17.00美元调整至13.00美元。
加载更多
公司概况
公司名称:
Cabaletta Bio
所属市场:
NASDAQ
上市日期:
--
主营业务:
Cabaletta Bio, Inc.于2017年4月根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司,专注于发现和开发工程化T细胞疗法,这些疗法有可能为患有自身免疫性疾病的患者提供一种深度和持久的,也许是治疗性的治疗。
发行价格:
--
{"stockData":{"symbol":"CABA","market":"US","secType":"STK","nameCN":"Cabaletta Bio","latestPrice":1.69,"timestamp":1752523200000,"preClose":1.74,"halted":0,"volume":1264411,"hourTrading":{"tag":"盘后","latestPrice":1.74,"preClose":1.69,"latestTime":"18:57 EDT","volume":11089,"amount":18826.6768,"timestamp":1752533866208},"delay":0,"floatShares":82631900,"shares":89943101,"eps":-2.566055,"marketStatus":"未开盘","change":-0.05,"latestTime":"07-14 16:00:00 EDT","open":1.76,"high":1.77,"low":1.65,"amount":2139447.7705198997,"amplitude":0.068966,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.566055,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752566400000},"marketStatusCode":0,"adr":0,"listingDate":1571976000000,"exchange":"NASDAQ","adjPreClose":1.74,"preHourTrading":{"tag":"盘前","latestPrice":1.7787,"preClose":1.74,"latestTime":"09:11 EDT","volume":5775,"amount":10005.43929,"timestamp":1752498689470},"postHourTrading":{"tag":"盘后","latestPrice":1.74,"preClose":1.69,"latestTime":"18:57 EDT","volume":11089,"amount":18826.6768,"timestamp":1752533866208},"volumeRatio":0.705106,"optionData":{"bulkOrders":[{"symbol":"CABA","call":true,"expireDate":1763701200000,"strike":"2.0","timestamp":1752515352780,"price":0.28,"volume":2500,"amount":70000,"type":"-"}]},"impliedVol":1.1042,"impliedVolPercentile":0.444},"requestUrl":"/m/hq/s/CABA","defaultTab":"news","newsList":[{"id":"2551806311","title":"Cabaletta Bio, Inc.盘中异动 急速下挫5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551806311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551806311?lang=zh_cn&edition=full","pubTime":"2025-07-15 00:04","pubTimestamp":1752509059,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日00时04分,Cabaletta Bio, Inc.股票出现异动,股价急速下跌5.14%。Cabaletta Bio, Inc.股票所在的生物技术行业中,整体涨幅为1.18%。Cabaletta Bio, Inc.公司简介:Cabaletta Bio Inc 是一家临床阶段的生物技术公司,专注于发现和开发工程化 T 细胞疗法,并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071500041997a5e015&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071500041997a5e015&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2550865929","title":"Cabaletta Bio, Inc.盘中异动 股价大涨5.26%报1.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550865929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550865929?lang=zh_cn&edition=full","pubTime":"2025-07-09 23:08","pubTimestamp":1752073714,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日23时08分,Cabaletta Bio, Inc.股票出现异动,股价急速拉升5.26%。Cabaletta Bio, Inc.股票所在的生物技术行业中,整体涨幅为1.30%。Cabaletta Bio, Inc.公司简介:Cabaletta Bio Inc 是一家临床阶段的生物技术公司,专注于发现和开发工程化 T 细胞疗法,并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709230834979fcbb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709230834979fcbb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2549558721","title":"Cabaletta Bio, Inc.盘中异动 早盘快速下挫5.83%报1.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549558721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549558721?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:36","pubTimestamp":1751895366,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时36分,Cabaletta Bio, Inc.股票出现异动,股价大幅下挫5.83%。Cabaletta Bio, Inc.股票所在的生物技术行业中,整体跌幅为0.64%。Cabaletta Bio, Inc.公司简介:Cabaletta Bio Inc 是一家临床阶段的生物技术公司,专注于发现和开发工程化 T 细胞疗法,并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213606a69b1b69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213606a69b1b69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2548886859","title":"Cabaletta Bio, Inc.盘中异动 快速上涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548886859","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548886859?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:19","pubTimestamp":1751386769,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时19分,Cabaletta Bio, Inc.股票出现波动,股价大幅上涨5.22%。Cabaletta Bio, Inc.股票所在的生物技术行业中,整体涨幅为1.42%。Cabaletta Bio, Inc.公司简介:Cabaletta Bio Inc 是一家临床阶段的生物技术公司,专注于发现和开发工程化 T 细胞疗法,并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702001929a728cbbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702001929a728cbbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2546729648","title":"Cabaletta Bio, Inc.盘中异动 临近收盘股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546729648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546729648?lang=zh_cn&edition=full","pubTime":"2025-06-28 03:50","pubTimestamp":1751053817,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日03时50分,Cabaletta Bio, Inc.股票出现异动,股价大幅下挫5.29%。Cabaletta Bio, Inc.股票所在的生物技术行业中,整体跌幅为0.74%。Cabaletta Bio, Inc.公司简介:Cabaletta Bio Inc 是一家临床阶段的生物技术公司,专注于发现和开发工程化 T 细胞疗法,并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035017952e7978&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035017952e7978&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2546275648","title":"Cabaletta Bio, Inc.盘中异动 股价大跌5.08%报1.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546275648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546275648?lang=zh_cn&edition=full","pubTime":"2025-06-27 03:35","pubTimestamp":1750966503,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日03时35分,Cabaletta Bio, Inc.股票出现异动,股价大幅下挫5.08%。Cabaletta Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.41%。Cabaletta Bio, Inc.公司简介:Cabaletta Bio Inc 是一家临床阶段的生物技术公司,专注于发现和开发工程化 T 细胞疗法,并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627033503a4bfa7fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627033503a4bfa7fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2545177919","title":"Cabaletta Bio, Inc.盘中异动 下午盘股价大涨5.16%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545177919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545177919?lang=zh_cn&edition=full","pubTime":"2025-06-21 03:20","pubTimestamp":1750447256,"startTime":"0","endTime":"0","summary":"北京时间2025年06月21日03时20分,Cabaletta Bio, Inc.股票出现波动,股价大幅上涨5.16%。截至发稿,该股报1.82美元/股,成交量119.001万股,换手率1.32%,振幅9.54%。Cabaletta Bio, Inc.股票所在的生物技术行业中,整体跌幅为0.56%。Cabaletta Bio, Inc.公司简介:Cabaletta Bio Inc 是一家临床阶段的生物技术公司,专注于发现和开发工程化 T 细胞疗法,并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621032056a4b52af4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621032056a4b52af4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2544906987","title":"Cabaletta Bio, Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544906987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544906987?lang=zh_cn&edition=full","pubTime":"2025-06-18 22:56","pubTimestamp":1750258601,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日22时56分,Cabaletta Bio, Inc.股票出现异动,股价大幅跳水5.09%。Cabaletta Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.89%。Cabaletta Bio, Inc.公司简介:Cabaletta Bio Inc 是一家临床阶段的生物技术公司,专注于发现和开发工程化 T 细胞疗法,并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618225641a4b0c04e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618225641a4b0c04e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2543609926","title":"Cabaletta Bio, Inc.盘中异动 早盘急速跳水5.03%报1.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543609926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543609926?lang=zh_cn&edition=full","pubTime":"2025-06-16 23:02","pubTimestamp":1750086141,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日23时02分,Cabaletta Bio, Inc.股票出现异动,股价大幅跳水5.03%。Cabaletta Bio, Inc.股票所在的生物技术行业中,整体跌幅为0.24%。Cabaletta Bio, Inc.公司简介:Cabaletta Bio Inc 是一家临床阶段的生物技术公司,专注于发现和开发工程化 T 细胞疗法,并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616230222a70c5995&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616230222a70c5995&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2542354865","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大涨5.08%报1.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542354865","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542354865?lang=zh_cn&edition=full","pubTime":"2025-06-12 22:24","pubTimestamp":1749738264,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日22时24分,Cabaletta Bio, Inc.股票出现波动,股价大幅拉升5.08%。截至发稿,该股报1.84美元/股,成交量121.912万股,换手率2.40%,振幅9.14%。Cabaletta Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.42%。Cabaletta Bio, Inc.公司简介:Cabaletta Bio Inc 是一家临床阶段的生物技术公司,专注于发现和开发工程化 T 细胞疗法,并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612222424951999aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612222424951999aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2542587087","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大跌19.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542587087","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542587087?lang=zh_cn&edition=full","pubTime":"2025-06-11 21:32","pubTimestamp":1749648768,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日21时32分,Cabaletta Bio, Inc.股票出现波动,股价急速跳水19.57%。Cabaletta Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.03%。Cabaletta Bio, Inc.公司简介:Cabaletta Bio Inc 是一家临床阶段的生物技术公司,专注于发现和开发工程化 T 细胞疗法,并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611213248a4a395d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611213248a4a395d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2542333552","title":"Cabaletta Bio, Inc.盘中异动 急速跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542333552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542333552?lang=zh_cn&edition=full","pubTime":"2025-06-09 23:05","pubTimestamp":1749481529,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日23时05分,Cabaletta Bio, Inc.股票出现波动,股价急速下跌5.04%。Cabaletta Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.66%。Cabaletta Bio, Inc.公司简介:Cabaletta Bio Inc 是一家临床阶段的生物技术公司,专注于发现和开发工程化 T 细胞疗法,并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609230530a700c8d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609230530a700c8d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2541845865","title":"Cabaletta Bio, Inc.盘中异动 早盘快速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541845865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541845865?lang=zh_cn&edition=full","pubTime":"2025-06-06 21:54","pubTimestamp":1749218049,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日21时54分,Cabaletta Bio, Inc.股票出现异动,股价大幅上涨5.05%。Cabaletta Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.72%。Cabaletta Bio, Inc.公司简介:Cabaletta Bio Inc 是一家临床阶段的生物技术公司,专注于发现和开发工程化 T 细胞疗法,并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060621540995116ffd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060621540995116ffd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2541076657","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541076657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541076657?lang=zh_cn&edition=full","pubTime":"2025-06-05 21:36","pubTimestamp":1749130604,"startTime":"0","endTime":"0","summary":"北京时间2025年06月05日21时36分,Cabaletta Bio, Inc.股票出现异动,股价大幅下挫5.10%。Cabaletta Bio, Inc.股票所在的生物技术行业中,整体跌幅为0.60%。Cabaletta Bio, Inc.公司简介:Cabaletta Bio Inc 是一家临床阶段的生物技术公司,专注于发现和开发工程化 T 细胞疗法,并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060521364495100cbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060521364495100cbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2540791952","title":"Cabaletta Bio, Inc.盘中异动 早盘快速上涨5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540791952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540791952?lang=zh_cn&edition=full","pubTime":"2025-06-02 22:54","pubTimestamp":1748876083,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日22时54分,Cabaletta Bio, Inc.股票出现波动,股价大幅拉升5.35%。Cabaletta Bio, Inc.股票所在的生物技术行业中,整体涨幅为1.34%。Cabaletta Bio, Inc.公司简介:Cabaletta Bio Inc 是一家临床阶段的生物技术公司,专注于发现和开发工程化 T 细胞疗法,并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602225445a496cec1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602225445a496cec1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2537326549","title":"Cabaletta Bio, Inc.盘中异动 股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537326549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537326549?lang=zh_cn&edition=full","pubTime":"2025-05-21 23:22","pubTimestamp":1747840937,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日23时22分,Cabaletta Bio, Inc.股票出现波动,股价大幅下跌5.31%。Cabaletta Bio, Inc.股票所在的生物技术行业中,整体跌幅为0.23%。Cabaletta Bio, Inc.公司简介:Cabaletta Bio Inc 是一家临床阶段的生物技术公司,专注于发现和开发工程化 T 细胞疗法,并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521232217aa2c9586&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521232217aa2c9586&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2536468926","title":"Cabaletta Bio, Inc.盘中异动 大幅下跌5.21%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536468926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536468926?lang=zh_cn&edition=full","pubTime":"2025-05-20 22:16","pubTimestamp":1747750593,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日22时16分,Cabaletta Bio, Inc.股票出现异动,股价急速下跌5.21%。Cabaletta Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.73%。Cabaletta Bio, Inc.公司简介:Cabaletta Bio Inc 是一家临床阶段的生物技术公司,专注于发现和开发工程化 T 细胞疗法,并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520221633a48587e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520221633a48587e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2536371126","title":"Cabaletta Bio(CABA.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.71美元,前值为-0.51美元,预期值为-0.66美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2536371126","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536371126?lang=zh_cn&edition=full","pubTime":"2025-05-20 04:01","pubTimestamp":1747684867,"startTime":"0","endTime":"0","summary":"Cabaletta Bio(CABA.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.71美元,前值为-0.51美元,预期值为-0.66美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/20040150517425.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CABA"],"gpt_icon":0},{"id":"2536135687","title":"Cabaletta Bio, Inc.盘中异动 大幅跳水5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536135687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536135687?lang=zh_cn&edition=full","pubTime":"2025-05-19 21:30","pubTimestamp":1747661443,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日21时30分,Cabaletta Bio, Inc.股票出现异动,股价快速下挫5.22%。Cabaletta Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。消息层面,截至21时30分,《Guggenheim:维持Cabaletta Bio评级,由买入调整至买入评级, 目标价由23.00美元调整至25.00美元。》资讯为影响Cabaletta Bio, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213043a48422b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213043a48422b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2535312435","title":"花旗:维持Cabaletta Bio(CABA.US)评级,由买入调整至买入评级, 目标价由17.00美元调整至13.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535312435","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535312435?lang=zh_cn&edition=full","pubTime":"2025-05-16 23:22","pubTimestamp":1747408924,"startTime":"0","endTime":"0","summary":"花旗:维持Cabaletta Bio(CABA.US)评级,由买入调整至买入评级, 目标价由17.00美元调整至13.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/16232250464243.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CABA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cabalettabio.com","stockEarnings":[{"period":"1week","weight":0.1342},{"period":"1month","weight":-0.1508},{"period":"3month","weight":0.5089},{"period":"6month","weight":-0.2387},{"period":"1year","weight":-0.7949},{"period":"ytd","weight":-0.2555}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0466},{"period":"3month","weight":0.1622},{"period":"6month","weight":0.054},{"period":"1year","weight":0.1158},{"period":"ytd","weight":0.0661}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cabaletta Bio, Inc.于2017年4月根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司,专注于发现和开发工程化T细胞疗法,这些疗法有可能为患有自身免疫性疾病的患者提供一种深度和持久的,也许是治疗性的治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.048317},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.157271},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.183657},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.082027},{"month":5,"riseRate":0.5,"avgChangeRate":0.078617},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.047367},{"month":7,"riseRate":0.666667,"avgChangeRate":0.020453},{"month":8,"riseRate":0.4,"avgChangeRate":-0.014107},{"month":9,"riseRate":0.6,"avgChangeRate":-0.036797},{"month":10,"riseRate":0.6,"avgChangeRate":0.296033},{"month":11,"riseRate":0.833333,"avgChangeRate":0.381738},{"month":12,"riseRate":0.5,"avgChangeRate":0.043168}],"exchange":"NASDAQ","name":"Cabaletta Bio","nameEN":"Cabaletta Bio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cabaletta Bio(CABA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cabaletta Bio(CABA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cabaletta Bio,CABA,Cabaletta Bio股票,Cabaletta Bio股票老虎,Cabaletta Bio股票老虎国际,Cabaletta Bio行情,Cabaletta Bio股票行情,Cabaletta Bio股价,Cabaletta Bio股市,Cabaletta Bio股票价格,Cabaletta Bio股票交易,Cabaletta Bio股票购买,Cabaletta Bio股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cabaletta Bio(CABA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cabaletta Bio(CABA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}